A Blood Clotting Test for People Having Surgery for a Glial Tumor
Official title: Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of Postoperative Thromboembolic Disease (GliTEM)
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study asks if a blood test can show who may get blood clots after brain tumor surgery.
Read our full plain-language summary
What the trial team says
The objective of our study is to investigate the clinical significance of thromboelastometric values in the development of thrombotic events and survival in patients with glial tumors, to reduce thromboembolic complications and optimize oncological treatment.
Key facts
- Registry number
- NCT07813377
- Conditions studied
- Glial Tumors, Thrombosis, Pulmonary Embolism (Diagnosis)
Where it is running
This trial lists 1 site.
-
Spain
- Hospital Clínic Barcelona (Barcelona)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.